Welcome to LookChem.com Sign In|Join Free

CAS

  • or

1417576-01-2

Post Buying Request

1417576-01-2 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

1417576-01-2 Usage

General Description

The chemical "(5-methyl-2-oxo-1,3-dioxol-4-yl)methyl 2-ethoxy-1-((2′-(4-ethyl-5-oxo-4,5-dihydro-1,2,4-oxadiazol-3-yl)-biphenyl-4-yl)methyl)-1H-benzo[d]imidazole-7-carboxylate" is a complex organic compound with a long and specific molecular structure. It contains various functional groups, including ester, carbonyl, ethoxy, oxadiazol, and biphenyl, and its chemical name reflects the presence of these groups. (5-methyl-2-oxo-1,3-dioxol-4-yl)methyl 2-ethoxy-1-((2′-(4-ethyl-5-oxo-4,5-dihydro-1,2,4-oxadiazol-3-yl)-biphenyl-4-yl)methyl)-1H-benzo[d]imidazole-7-carboxylate may have potential pharmaceutical or research applications due to its intricate structure and functional groups, but further study would be necessary to understand its specific properties and potential uses.

Check Digit Verification of cas no

The CAS Registry Mumber 1417576-01-2 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,4,1,7,5,7 and 6 respectively; the second part has 2 digits, 0 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 1417576-01:
(9*1)+(8*4)+(7*1)+(6*7)+(5*5)+(4*7)+(3*6)+(2*0)+(1*1)=162
162 % 10 = 2
So 1417576-01-2 is a valid CAS Registry Number.

1417576-01-2Downstream Products

1417576-01-2Relevant articles and documents

Improved process for azilsartan medoxomil: A new angiotensin receptor blocker

Radl, Stanislav,Cerny, Josef,Stach, Jan,Gablikova, Zuzana

, p. 77 - 86 (2013/03/28)

An improved process for the active pharmaceutical ingredient of a new angiotensin II AT1 receptor antagonist, azilsartan medoxomil, has been developed. The results include reinvestigation of the described process as well as its novel modifications. This new process includes transformation of the CN group into amidoxime moiety by aqueous hydroxylamine, its cyclization into the corresponding oxadiazole by treatment with dialkyl carbonates, and the following hydrolysis of the ester and transformation into the medoxomil ester. Several thus far undocumented side products were identified, and some of them were synthesized and duly characterized as potential impurities. Formation and control of possible critical impurities are described.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 1417576-01-2